Discovery of a new molecule by the Olmix Group in Algae

The Olmix group and the French National Public Institute for Agronomic Research (INRAe) have collaborated to demonstrate the effect of algae on the modulation of immune mediators in cellular models and in animals, including the identification of the metabolic pathways involved in this activation (Berri et al. 2016 and 2017).


Preclinical collaborations with research institutes led to the discovery of the molecules involved in the immunostimulation and the mechanism of action.

Biochemical research in USA and Europe led to the discovery of the molecules involved in the modulation of the immune system called the Marine Sulfated Polysaccharides (MSP).

Research between Olmix group and University of Nantes and Rennes 1 are engaged to study the effect of MSP and other molecules on the immune system and pathogens in relevant clinical models. Preclinical studies show very promising results on immunodepressed and infected models and patents are filled.

June 2019

The project is awarded with grand laureate I-Lab price of the BPIFrance

The project MAPOLI (Marine Polysaccharides for Immunity) is granted grand Lauréat for the 2019 edition of the i-Lab competition

November 2019

Foundation of Olgram

March 2020

Seed fund raising of 2M to develop the new molecule and unique tools necessary to the study of the chronicity of infections.

April 2020

Olgram receive the support from the Britanny region via its Inno R&D collaborative.

April 2021

Olgram designed as Gold company by the European Investor Network.

Dec 2022

Winner of Tech Tour France Transfer Invest 22


We create a company that will save the life of many patients while creating a virtuous industrial process.

Learn more


Our pipeline: Delivering first-in-class immunotherapies of activation and regulation. We develop 2 different classes of therapeutic molecules in our 2 areas of expertise within our proprietary research platform: immunology and infectiology.

Learn more